FDA Approves First New Weight-Loss Drug In More Than A Decade

The Food and Drug Administration gave the green light to Belviq, a twice-a-day pill that suppresses appetite and appears to affect metabolism by influencing levels of the brain chemical serotonin. The agency had previously rejected the drug over concerns about safety.Read More[category World]